Association between haemoglobin A1c and cerebral microbleeds in community‐based stroke‐free individuals: A cross‐sectional study. Issue 6 (18th June 2022)

• Record Type: Journal Article
• Authors: Yu, Miaoxin; Jia, Yanan; Yang, Dandan; Zhang, Runhua; Jiang, Yong; Zhang, Guitao; Qiao, Huiyu; Han, Hualu; Shen, Rui; Ning, Zihan; Zhao, Xihai; Liu, Gaifen; Wang, Yongjun
• Is Part Of: Diabetes/metabolism research and reviews. Volume 38:Issue 6(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-06-18
• Subjects: cerebral microbleeds -- diabetes mellitus -- haemoglobin A1c -- susceptibility‐weighted imaging; Diabetes -- Periodicals; Metabolism -- Periodicals; 616.642
• DOI: 10.1002/dmrr.3557
• Languages: English
• ISSNs: 1520-7552

Abstract

Abstract: Aims: The association between haemoglobin A1c (HbA1c) and cerebral microbleeds (CMBs) remains unclear. We aimed to investigate the association between HbA1c and CMBs in community‐based individuals without stroke or transient ischaemic attack (TIA) and whether the association differs between individuals with and without diabetes mellitus (DM). Materials and Methods: All individuals were recruited from a community in Beijing, China, from January 2015 to September 2019. All individuals completed a questionnaire and underwent blood tests and brain magnetic resonance imaging. A susceptibility‐weighted imaging sequence was acquired to detect CMBs, which were defined as small, round and low‐signal lesions with <10 mm diameter. The association between HbA1c and CMBs was analysed using multivariable logistic regression adjusted for demographics, medical history and blood sample test results. Subgroup analyses stratified by history of DM were performed. Results: Of 544 recruited individuals, 119 (21.88%) had CMBs. HbA1c was independently associated with CMBs (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.03–2.22). In 87 individuals with DM, multivariable logistic analysis showed that HbA1c was significantly associated with CMBs (OR, 1.67; 95% CI, 1.04–2.69), whereas in individuals without DM, no significant association was observed between HbA1c and CMBs (OR, 1.07; 95% CI, 0.50–2.30). Conclusions: HbA1c was associated with CMBs in individuals without stroke or TIA, particularly in individuals with DM, suggesting that the status of glycaemic control warrants attention for the prevention of CMBs. It would be beneficial to manage HbA1c specifically to control the risk of CMBs, especially in individuals with DM.